1 janv. 1962 - Kefauver-Harris Amendment of 1962
Description:
Expanded pre-market approval burden to include adequate proof that a drug is effective for its indicated use, not merely safe
Also added GMP requirement for manufacturers, violation of which amounts to adulteration
Ajouté au bande de temps:
Date: